Financials
| 2023 Annual Financial Report | Oct. 30, 2023 |
| Availability of the 2023 Annual Financial Report | Oct. 17, 2023 |
| Preliminary results - year ended 30 June 2023 | Oct. 12, 2023 |
| Trading Update | May. 22, 2023 |
| Half-year Report - six months to 31 December 2022 | Feb. 27, 2023 |
| Trading Update and Notice of Results | Jan. 12, 2023 |
| Posting of 2022 Annual Financial Report | Sep. 20, 2022 |
Proxies
| Result of AGM | Dec. 13, 2023 |
| 2023 Notice of the Annual General Meeting | Nov. 14, 2023 |
| Dechra Pharmaceuticals PLC - 2022 AGM - Special resolutions passed | Oct. 20, 2022 |
| Result of AGM | Oct. 20, 2022 |
| AGM -Trading Update | Oct. 20, 2022 |
| Dechra - 2022 AGM - Form of Proxy | Sep. 20, 2022 |
| Dechra - Notice of 2022 Annual General Meeting | Sep. 20, 2022 |
Ownership Update
| Holding(s) in Company | Jan. 23, 2024 |
| Holding(s) in Company | Jan. 17, 2024 |
| Holding(s) in Company | Jan. 17, 2024 |
| Holding(s) in Company | Jan. 17, 2024 |
| Holding(s) in Company | Jan. 17, 2024 |
| Holding(s) in Company | Jan. 17, 2024 |
| Holding(s) in Company | Jan. 16, 2024 |
Announcements
| Holding(s) in Company | Jan. 18, 2024 |
| Scheme of Arrangement becomes Effective | Jan. 16, 2024 |
| Court sanction of Scheme of Arrangement | Jan. 12, 2024 |
| Total Voting Rights | Dec. 29, 2023 |
| Rule 2.9 Announcement | Dec. 18, 2023 |
| Director Declaration | Dec. 14, 2023 |
| Rule 2.9 Announcement | Dec. 13, 2023 |
Prospectuses
| Publication of Prospectus | Apr. 25, 2012 |